Tradestie Institutional Equity Comparison Engine

ABCL vs CHNR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CHNR Overall Edge

CHNR Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to China Natural Resources, Inc. (CHNR) driven by superior Valuation, Growth & Margin, Options & Structure while ABCL counters with relative strength in Momentum & Technical. Fundamentally, ABCL trades at 27.6x Forward P/E with -298.0% operating margin (+18.8% YoY revenue) versus CHNR at 7.8x Forward P/E and 0.0% operating margin (-24.0% YoY). In options structure, ABCL sits in BREAKDOWN (32nd %ile IV; Dealer Gamma Walls on Pro) against CHNR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner CHNR
ABCL 27.6x vs CHNR 7.8x Fwd P/E
Growth & Margin Winner CHNR
Op Margin -298.0% vs 0.0% ยท YoY +18.8% vs -24.0%
Momentum & Technical Winner ABCL
1Y +168.4% vs -26.2% ยท 52W Pos 57% vs 0%
Options & Structure Winner CHNR
BREAKDOWN (32nd %ile IV) vs UNCLASSIFIED (N/A IV)
ABCL NASDAQ
AbCellera Biologics Inc. Common Shares
Pharmaceutical Preparations
$9.69
-7.45% 1D
Market Cap $3.4B
1M Return -14.78%
1Y Return +168.42%
Forward P/E 27.6x
Unified AI Score
57.1 / 100 HOLD
Tech 33.0 Fund 54.0 Flow 70.0 Mom 64.0
CHNR NASDAQ
China Natural Resources, Inc.
Wholesale-Miscellaneous Nondurable Goods
$2.98
-0.33% 1D
Market Cap $3.8M
1M Return -26.24%
1Y Return -26.24%
Forward P/E 7.8x
Unified AI Score
43.4 / 100 HOLD
Tech 35.0 Fund 42.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABCL +168.42% CHNR -26.24% Spread: +184.73 pp (ABCL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABCL TTM Op. Margin: -298.0% CHNR TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABCL vs CHNR. Trailing 12-month operating profitability (ABCL -298.0% vs CHNR 0.0%) and valuation multiples (ABCL 27.6x vs CHNR 7.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABCL (4) vs CHNR (6)
Institutional Metric ABCL CHNR Criterion Row Winner
Market Capitalization Scale $3.4B $3.8M Larger Scale ABCL
Trailing P/E Ratio Valuation 27.6x 7.8x Lower Multiple CHNR
Forward P/E Ratio Valuation 27.6x 7.8x Lower Multiple CHNR
Revenue Growth (YoY) Growth +18.8% -24.0% Higher Growth ABCL
Operating Margin (TTM) Profitability -298.0% 0.0% Higher Margin CHNR
Net Profit Margin Profitability -218.6% 0.0% Higher Margin CHNR
Return on Equity (ROE) Capital Efficiency -14.6% -1.4% Higher ROE CHNR
52-Week Range Position Momentum 57% ($3โ€“$15) 0% ($3โ€“$6) Stronger Trend ABCL
Beta / 30D Volatility Risk Regime 2.32ฮฒ ยท 85% Vol 1.15ฮฒ ยท 53% Vol Lower Realized Risk CHNR
Unified Institutional Score Composite Signal 57.1 / 100 (HOLD) 43.4 / 100 (HOLD) Higher Composite ABCL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABCL vs CHNR Buy Guide
ABCL BREAKDOWN
38d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 32nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ABCL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CHNR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CHNR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABCL nor CHNR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.